A patient with severe acute pancreatitis successfully treated with a new critical care procedure.

T. Moriguchi, H. Hirasawa, S. Oda, H. Shiga, K. Nakanishi, K. Matsuda, Masataka Nakamura, K. Yokohari, Takeshi Hirano, Y. Hirayama, Eizo Watanabe
{"title":"A patient with severe acute pancreatitis successfully treated with a new critical care procedure.","authors":"T. Moriguchi, H. Hirasawa, S. Oda, H. Shiga, K. Nakanishi, K. Matsuda, Masataka Nakamura, K. Yokohari, Takeshi Hirano, Y. Hirayama, Eizo Watanabe","doi":"10.1046/J.1526-0968.2002.00435.X","DOIUrl":null,"url":null,"abstract":"It has been accepted widely that excessive humoral mediators play important roles in the pathogenesis of organ failure in patients with severe acute pancreatitis (SAP) and that infection of the pancreas due to bacterial translocation (BT) is the most frequent cause of death in SAP. On the other hand, it has been reported that continuous hemodiafiltration (CHDF) removes humoral mediators on hypercytokinemic patients such as those with systemic inflammatory response syndrome. Furthermore, several clinical studies have demonstrated that selective digestive decontamination (SDD) effectively eliminates aerobic Gram-negative bacteria from the intestinal tract and reduces the incidence of septic complications in SAP. Herein we report a case of SAP who was treated successfully with intensive care including CHDF and SDD. Thus, this case report suggests that CHDF aimed at removing causative humoral mediators and SDD for the prevention of BT are useful new tools for the management of SAP.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2002-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1046/J.1526-0968.2002.00435.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

It has been accepted widely that excessive humoral mediators play important roles in the pathogenesis of organ failure in patients with severe acute pancreatitis (SAP) and that infection of the pancreas due to bacterial translocation (BT) is the most frequent cause of death in SAP. On the other hand, it has been reported that continuous hemodiafiltration (CHDF) removes humoral mediators on hypercytokinemic patients such as those with systemic inflammatory response syndrome. Furthermore, several clinical studies have demonstrated that selective digestive decontamination (SDD) effectively eliminates aerobic Gram-negative bacteria from the intestinal tract and reduces the incidence of septic complications in SAP. Herein we report a case of SAP who was treated successfully with intensive care including CHDF and SDD. Thus, this case report suggests that CHDF aimed at removing causative humoral mediators and SDD for the prevention of BT are useful new tools for the management of SAP.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症急性胰腺炎患者成功治疗与新的重症监护程序。
人们普遍认为,过量的体液介质在严重急性胰腺炎(SAP)患者器官衰竭的发病机制中起着重要作用,细菌易位(BT)引起的胰腺感染是SAP患者最常见的死亡原因。另一方面,有报道称,持续血液滤过(CHDF)可清除高细胞动力学患者(如全身性炎症反应综合征)的体液介质。此外,一些临床研究表明,选择性消化去污(SDD)可以有效地消除肠道中的需氧革兰氏阴性菌,减少SAP患者脓毒性并发症的发生率。在此,我们报告了一例SAP患者通过重症监护室治疗成功,包括CHDF和SDD。因此,本病例报告表明,CHDF旨在去除致病体液介质和SDD预防BT是管理SAP的有用新工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Presidential Address: PRESIDENTIAL ADDRESS Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Mobilization factors of peripheral blood stem cells in healthy donors. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. In vitro evaluation of newly developed adsorbent for selective removal of glycosylated low-density lipoprotein.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1